Latest News
Agios plunged 48% after its Phase III Pyrukynd trial delivered mixed results, missing key pain-crisis and fatigue endpoints. Despite strong hemoglobin gains, AGIO still seeks ...
US stocks rose on Wednesday, setting up a fourth day win as investors welcomed rising odds of a December rate cut and showed a fresh ...
Priority Tech faces turmoil as major holder Steamboat blasts the CEO’s go-private bid as too low. With improving results and the CEO controlling 50%+, a ...
Sprout Social drew attention after takeover rumors linked Adobe to a possible bid. Strong 13% revenue growth, record margins, and AI traction fuel speculation, but ...





























